Location:Home > Pharmaceutical
Product
Reputable manufacturer supply Sodium 4-phenylbutyrate 1716-12-7 in stock with high standard
- Molecular Formula: C10H11NaO2
- Molecular Weight: 186.186
- Vapor Pressure: 0.00288mmHg at 25°C
- Melting Point: 207°C (dec.)(lit.)
- Boiling Point: 290.7 °C at 760 mmHg
- Flash Point: 187.9 °C
- PSA: 40.13000
- Density: 1.095g/cm3
- LogP: 0.75920
Sodium 4-phenylbutyrate(Cas 1716-12-7) Usage
|
Biological Activity |
Sodium 4-Phenylbutyrate is a histone deacetylase inhibitor that displays anticancer activity. Inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. Also inhibits protein isoprenylation, depletes plasma glutamine, increases production of fetal hemoglobin through transcriptional activation of the γ-globin gene and affects hPPARγ activation. |
|
Biochem/physiol Actions |
Sodium phenylbutyrate is a histone deacetylase inhibitor. |
|
Definition |
ChEBI: The organic sodium salt of 4-phenylbutyric acid. A prodrug for phenylacetate, it is used to treat urea cycle disorders. |
|
Brand name |
Buphenyl (Medicis). |
|
General Description |
An antineoplastic agent that demonstrates potent differentiating capacity in multiple hematopoietic and solid tumor cell lines. Acts as an inducer of tumor cytostasis and differentiation as well as of peroxisomal proliferation. A more effective inhibitor of histone deacetylase and inducer of histone acetylation than its structural analogs including 2- and 3-phenylbutyrate. Acts as a transcriptional regulator and improve the targeting of δF508-CFTR (cystic fibrosis transmembrane regulator) for ubiquitination and degradation by reducing the expression of HSC70 in epithelial cells. Also, reported to increase fetal hemoglobin production in vitro and in vivo. |
InChI:InChI=1/C10H12O2.Na/c1-2-9(10(11)12)8-6-4-3-5-7-8;/h3-7,9H,2H2,1H3,(H,11,12);/q;+1/p-1
1716-12-7 Relevant articles
Intermolecular Reductive Heck Reaction of Unactivated Aliphatic Alkenes with Organohalides
Zheng, Kewang,Xiao, Guanlin,Guo, Tao,Ding, Yalan,Wang, Chengdong,Loh, Teck-Peng,Wu, Xiaojin
supporting information, p. 694 - 699 (2020/01/31)
A general intermolecular reductive Heck ...
Preparation method of sodium phenylbutyrate
-
Paragraph 0014; 0028-0032, (2019/10/22)
The invention discloses a preparation me...
Preparation method for sodium phenylbutyrate
-
Paragraph 0084; 0089, (2017/06/29)
The invention discloses a preparation me...
Use of 4-phenylbutyric acid and/or salts thereof for enhancing stress tolerance in plants
-
Page/Page column 3, (2012/04/05)
The invention relates to the use of 4-ph...
1716-12-7 Process route
-
-
1821-12-1
4-Phenylbutyric acid
-
-
1716-12-7
Ammonaps
| Conditions | Yield |
|---|---|
|
With
sodium hydroxide;
In
water;
|
96%
|
|
With
sodium hydroxide;
In
ethanol;
for 4h;
Industrial scale;
|
88.2%
|
|
With
sodium carbonate;
In
methanol;
at 60 ℃;
for 0.75h;
|
|
|
With
sodium carbonate;
In
methanol;
at 60 ℃;
for 0.75h;
|
|
|
With
sodium hydroxide;
In
water;
|
|
|
With
sodium hydroxide;
In
ethanol;
for 8h;
Reflux;
|
-
-
1449300-08-6
4-phenyl-N-(quinolin-8-yl)butanamide
-
-
1716-12-7
Ammonaps
| Conditions | Yield |
|---|---|
|
With
sodium hydroxide;
In
ethanol;
for 12h;
Reflux;
|
98%
|
|
With
sodium hydroxide;
In
ethanol;
at 130 ℃;
for 14h;
Sealed tube;
|
98%
|
1716-12-7 Upstream products
-
1821-12-1
4-Phenylbutyric acid
-
1449300-08-6
4-phenyl-N-(quinolin-8-yl)butanamide
-
108-86-1
bromobenzene
-
578-66-5
8-amino quinoline